Perth, May 9, 2017 AEST (ABN Newswire) – MMJ PhytoTech Limited (ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that the Company’s Australian distribution partner, Melbourne-based HL Pharma Pty Ltd. (“HL Pharma”), has successfully imported its first shipment of medicinal products from the Company’s Swiss-subsidiary, Satipharm AG, (“Satipharm”).
– HL Pharma Pty Ltd successfully imports first shipment of Satipharm’s Gelpell CBD capsules into Australia under new Government legislation
– Importation includes two strengths of Gelpell CBD capsules to be stored at secure HL Pharma facility prior to Australia-wide distribution in compliance with Federal and State legislation
– Gelpell CBD capsules are one of the first medicinal cannabis products available to approved prescribers in Australia
The imported products include two strengths of cannabidiol capsules, which are able to be used in the treatment of a variety of medical